Circ_0008777 promotes head and neck squamous cell carcinoma progression by elevating c-Myc expression levels via interacting with PC4 and miR-185–3p Authors: Weixing Liu, Zhiyuan Wang, Pei Li, Yue Liu, Jia Chen, Zhi Shi, Hui Liu, Jin Ye Published: 2026 ABSTRACT Highlights•Circ_0008777 is upregulated in HNSCC and correlates with poor prognosis.•Circ_0008777 binds PC4 to enhance c-Myc transcription in HNSCC cells.•Circ_0008777 acts as a sponge for miR-185–3p, relieving c-Myc repression.•Circ_0008777 promotes HNSCC progression via c-Myc upregulation in vitro and in vivo.•Targeting circ_0008777 may offer a novel therapeutic strategy for HNSCC.Keywords: Circ_0008777, PC4, miR-185–3p, c-Myc, HNSCC Introduction Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers [1]. HNSCC mainly occurs in the oral cavity, pharynx, and larynx. Unfortunately, more than 60% of new cases are diagnosed at an advanced stage, resulting in a poor prognosis [2]. Thus, it is crucial to study HNSCC pathogenesis to identify early detection biomarkers and new therapeutic targets. Growing evidence suggests that circular RNAs (circRNAs) play critical roles in tumor progression [3]. However, how circRNAs can regulate the molecular dynamics of HNSCC remains largely unknown. CircRNAs are a class of covalently closed-loop RNA molecules, which do not have a 5′ cap or 3′ polyadenylated tail [4]. CircRNAs are more stable than linear RNAs because of their anti-RNase R properties. Thus, circRNAs have unique advantages as biomarkers of disease diagnosis and prognosis. Increasing evidence indicates that circRNAs are involved in the hallmarks of HNSCC, including proliferation and cell cycle progression, tumor invasion and metastasis, and chemotherapy resistance [5,6]. Previous reports have suggested that circRNAs encoded by certain oncogenes are involved in malignant tumor progression [7]. For example, circMyc encoded by the Myc gene can contribute to the occurrence and development of triple negative breast cancer by regulating metabolic reprogramming [8]. Additionally, the EGFR gene encodes circEGFR, which can promote colon cancer cell proliferation, migration, and invasion through the miR-106a-5p/DX5/AKT axis [9]. AURKA, the well-documented proto-oncogene, is frequently overexpressed in various human cancers. High AURKA expression can promote tumor c-Myc expression, the epithelial-mesenchymal transition, cell cycle progression, and tumor drug resistance [10,11]. Not surprisingly, AURKA expression levels are significantly increased in HNSCC [12]. Transcriptome sequencing studies have found that an AURKA gene-encoded circRNA, called circ_0008777, is highly expressed in HNSCC tissues [13]. However, the function of circ_0008777 in HNSCC is unknown. In this study, we examined the expression patterns of AURKA-derived circRNAs in HNSCC, finding that circ_0008777 (hsa_circ_0008777) expression levels were frequently increased in HNSCC. Further investigations showed that circ_0008777 can promote HNSCC progression via interacting with positive cofactor 4 (PC4) and miR-185–3p. Materials and methods Patient tissue specimens HNSCC tissues and matched adjacent normal epithelial tissues were obtained from 60 HNSCC patients treated at the Third Affiliated Hospital of Sun Yat-sen University between 2019 and 2024 (Table S1). All patients were newly diagnosed with HNSCC and did not receive chemotherapy or neoadjuvant therapy before surgery. Two experienced clinical pathologists diagnosed the tissue samples independently. Cell culture, RNA extraction, qPCR, and western blot analysis The human HNSCC cell lines Cal27 and Fadu were provided by Procell Life Science & Technology Co., Ltd. (Wuhan, China), the LSCC cell line Tu212 was provided by iCell Bioscience Inc. (Shanghai, China), the oral keratinocyte cell lines (NOK) were kindly provided by Professor Zhi Shi's research group at Jinan University, and the HEK293T cell line was obtained from China Center for Type Culture Collection (CCTCC). The cells were maintained under standard culture conditions (37 °C, 5% CO₂, humidified atmosphere) in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin. Total RNA was extracted from cells and tissues using the HiPure Total RNA Mini Kit (Magen, Guangzhou, China) according to the manufacturer’s instructions. Then, qPCR and western blot analyses were performed as described previously [14]. For MG132 treatment, cells were incubated with 10 μM MG132 or DMSO control for 6 h prior to protein extraction. The antibodies used for western blot analysis were as follows: anti-PC4 antibody (14,326-MM04–100, Sino Biological, Beijing, China), anti-c-Myc antibody (551,102, BD Pharmingen™, BD Biosciences, San Jose, CA, USA), anti-β-Tubulin antibody (30302ES60, YEASEN, Wuhan, China), and anti-vinculin antibody (sc-73,614, Santa Cruz Biotechnology, Dallas, TX, USA). The specific primer sequences used in this study are included in Table S2. RNase R and actinomycin D assays Total RNA (1 μg) was incubated at 37 °C for 15 min with or without 3 U/μg RNase R (Geneseed, Guangzhou, China). PCR using divergent or convergent primers were used to detect the circRNAs or linear RNAs. Cal27, Tu212 and Fadu cells were seeded in a 6-well plate overnight, at a density of 2 × 10⁵ cells per well, and treated with 2 µg/mL actinomycin D (Sigma-Aldrich, St. Louis, MO, USA) for 4, 8, or 12 h. The cells were collected at the indicated times, then the expression levels of circ_0008777 and AURKA mRNA were analyzed using qPCR. Fluorescence in situhybridization (FISH) and cellular fractionation assay Cy3-labeled circ_0008777 probes (5′-TGGAGCTGTAGCAGTAGCAGTTCTC-3′) were synthesized by BGI TECH SOLUTIONS (Beijing, China). FISH was conducted using a FISH kit (RiboBio, Guangzhou, China) following the manufacturer’s protocols. DAPI was used as a nuclear counterstain. Images were acquired using a ZEISS LSM900 Confocal Microscope system (Carl Zeiss AG, Oberkochen, Germany).‌ Nuclear-cytoplasmic fractionation was conducted using the Cytoplasmic & Nuclear RNA Purification Kit (Norgen Biotek, Thorold, Canada) according to the manufacturer’s protocol. The subcellular location of circ_0008777 was assessed by qPCR, with U1 snRNA serving as the nuclear compartment control and β-actin mRNA serving as the cytoplasmic purity marker. Plasmid construction A short hairpin RNA (shRNA) lentiviral plasmid targeting circ_0008777 and a control shRNA-NC were constructed by inserting the annealed shRNA template DNA sequence (Table S2) into the pLKO.1 vector. The circ_0008777 sequence and a control OE-NC were cloned into the plc5.ciR overexpression plasmid (Geneseed, Guangzhou, China). To generate stable cell lines, CRISPR/Cas9 technology was used. Two single guide RNAs targeting human PC4 (Table S2) were constructed into the LentiCRISPR V2 vector. Stable cell lines were constructed by infecting each lentivirus into Cal27 and Tu212 cells, followed by puromycin selection (2 μg/mL). Cell counting kit-8 (CCK-8) assay Cells were seeded into 96-well plates (3 × 103 cells/well) 24 h after transfection. At 0, 24, 48, 72, and 96 h, the medium in each well was replaced with 100 μL fresh complete medium and 10 μL CCK-8 reagent (YEASEN, Shanghai, China), followed by incubation at 37 °C with 5% CO2 for 1 hour. A multifunctional microplate detection system was then used to measure the absorbance value of each well. The wound healing, Transwell, and colony formation assays were performed as described previously [14]. The detailed procedures of the luciferase reporter assay, biotin RNA pull-down assay, RNA immunoprecipitation (RIP) assay, chromatin immunoprecipitation (ChIP) assay, label-free quantitative proteomics, and bioinformatics analysis are provided in the Supplementary Materials and Methods. Xenograft tumorigenesis Nude mice (6–8 weeks old) were obtained from Guangdong Yaokang Biotechnology Co., Ltd. (Guangzhou, China). A total of 2 × 106 Cal27 cells were collected in 100 µL of serum-free DMEM and injected subcutaneously into the axilla of each mouse. Tumor volumes were measured after cultivation for seven days. The tumor volume was calculated as follows: Volume = (length × width2)/2. At day 28 post-inoculation, the mice were sacrificed, then the tumors were weighed and processed for RNA extraction histological analysis, which was performed as described previously [14]. This animal experiment was conducted in accordance with the ARRIVE reporting guidelines [15]. The animal experiments were performed during November and December 2022. For comprehensive methodological details, please refer to the Supplementary Materials and Methods. Statistical analysis Data analysis was performed using the statistical software SPSS (version 25) and GraphPad Prism (version 8.0.1). For comparisons between two groups, unpaired two-tailed Student's t-tests were conducted. When comparing more than two groups, one-way ANOVA with Tukey's post hoc test was employed. Receiver operating characteristic (ROC) curve analyses were conducted for prognostic assessments. P-values < 0.05 were considered statistically significant. Results Circ_0008777 is overexpressed in HNSCC tissues The back spliced sequence of circ_0008777 was confirmed by Sanger sequencing (Fig. 1A). The divergent primers could amplify circ_0008777 in cDNA samples, but no PCR products were detected when using genomic DNA (gDNA) samples (Fig. 1B). Circ_0008777 was resistant to RNase R treatment, demonstrating its circular structure (Fig. 1C). Furthermore, the results of subcellular fractionation and FISH assays revealed that circ_0008777 was localized in both the nucleus and cytoplasm of HNSCC cells (Fig. 1D, E). We further confirmed that circ_0008777 remained more stable than AURKA mRNA after treatment with actinomycin D (Fig. 1F). The qPCR results revealed that circ_0008777 expression levels were upregulated in HNSCC cell lines (Fig. 1G) and tissues (Fig. 1H). Furthermore, high circ_0008777 expression levels were positively correlated with T stage, N stage, and clinical stage (Fig. 1I–K). Additionally, circ_0008777 levels showed only modest diagnostic value for distinguishing HNSCC tissues from adjacent normal tissues, with an area under the receiver operating characteristic curve (AUC) value of 0.67 (Fig. 1L). Further validation in larger cohorts is needed to assess its clinical utility. Structural characterization, cellular localization, and expression profile of circ_0008777. A: circ_0008777 is derived from exons 3, 4, 5, and 6 of the AURKA gene, with Sanger sequencing of the PCR product confirming the cyclization site. B: Both circ_0008777 and AURKA mRNA can be amplified from cDNA samples, while only AURKA mRNA can be amplified from gDNA samples. C: The expression levels of circ_0008777 and AURKA mRNA were analyzed in total RNA extracted from Cal27, Tu212, and Fadu cells for both RNase R-treated and untreated samples. D: The distribution of circ_0008777 was detected in Cal27, Tu212, and Fadu cells using qPCR. E: FISH experiments showed that circ_0008777 is localized in both the nucleus and cytoplasm of Cal27 and Tu212 cells. F: Cal27, Tu212, and Fadu cells were treated with actinomycin D (2 μg/mL) for various times, followed by qPCR analysis to assess the circ_0008777 and AURKA mRNA expression levels. G: Compared with NOK, circ_0008777 expression levels were significantly elevated in the Cal27 and Tu212 cell lines. H: Circ_0008777 expression levels are significantly upregulated in HNSCC tissues. I: Circ_0008777 expression levels are higher in HNSCC T3–4 patients than in T1–2 patients. J: Circ_0008777 expression levels are higher in HNSCC N1–3 patients than in N0 patients. K: Circ_0008777 expression levels are higher in HNSCC stage III–IV patients than in stage I–II patients. L: ROC curve analysis showing the modest diagnostic value of circ_0008777 for distinguishing HNSCC tissues from adjacent normal tissues (AUC = 0.67). Data are shown as the mean ± SD. Student’s t-tests were used for statistical analysis; *P < 0.05; **P < 0.01. Circ_0008777 promotes HNSCC cell proliferation and migration in vitro The circ_0008777 overexpression and knockdown efficiencies in these cells were validated by qPCR analysis (Fig. 2A–D, Figure S1A–C). Cell viability was comprehensively assessed using CCK-8 and colony formation assays, which demonstrated that circ_0008777 knockdown suppressed cell proliferation, while circ_0008777 overexpression promoted cell proliferation (Fig. 2E–H, Figure S1D–G). Furthermore, the Transwell and wound healing assay data revealed that the HNSCC cell migration rates were significantly diminished upon circ_0008777 knockdown and substantially enhanced with circ_0008777 overexpression (Fig. 2I–K, Figure S1H, Figure S2A–C). Taken together, these findings indicate that circ_0008777 acts as an oncogenic factor, enhancing HNSCC cell proliferation and migration in vitro. Knocking down circ_0008777 suppresses HNSCC cell proliferation and migration In vitro. A: Design of the circ_0008777 shRNA interference sequence. B–D: Effects of the different shRNA interference sequences on the circ_0008777 and AURKA mRNA expression levels in (B) Cal27, (C) Tu212, and (D) Fadu cells. E–G: CCK-8 results showing that knocking down circ_0008777 can inhibit the proliferation of © Cal27, (F) Tu212, and (G) Fadu cells. H: Knocking down circ_0008777 could inhibit clone formation in Cal27, Tu212, and Fadu cells. I: The impacts of circ_0008777 knockdown on Cal27, Tu212, and Fadu cell migration were evaluated through Transwell migration assays. J, K: Scratch assays were conducted following circ_0008777 knockdown in Cal27, Tu212, and Fadu cells. Data are shown as the mean ± SD. Student’s t-tests were employed for statistical analysis; *P < 0.05; **P < 0.01. Circ_0008777 promotes the tumorigenesis of HNSCC cells in vivo Using a subcutaneous tumor formation model with Cal27 cells, circ_0008777 knockdown was found to potently suppress tumor growth, while its overexpression significantly stimulated tumorigenesis (Fig. 3A, Figure S3A). Compared with the control group, the circ_0008777 knockdown group displayed a substantial reduction in both tumor volume (Fig. 3B). In contrast, the circ_0008777 overexpression group exhibited a pronounced increase in tumor volume (Figure S3B, C). Next, qPCR was used to detect circ_0008777 expression in the xenograft tumors (Fig. 3C, Figure S3D). Additionally, we then conducted label-free quantitative proteomics on Tu212 cells with circ_0008777 knockdown. Compared with the shRNA-NC group, 342 differentially expressed proteins were identified in the circ_0008777 knockdown group, including 138 upregulated proteins and 204 downregulated proteins (Fig. 3D). KEGG analysis indicated that the downregulated proteins were significantly enriched in pathways such as “Ubiquitin-mediated proteolysis,” “Cell cycle,” “Metabolic pathways,” and “Platinum drug resistance” (Fig. 3E). These results suggest that circ_0008777 can stimulate HNSCC cell proliferation in vivo. Knocking down circ_0008777 suppresses HNSCC tumor growth In vivo. A: Subcutaneous transplant tumor model, including tumor size and morphology. B: Tumor growth curve. C: The circ_0008777 expression levels in the tumor tissues. D: Volcano plot of differentially expressed proteins. E: KEGG pathway bubble plot of the top 20 significantly enriched downregulated proteins. Data are shown as the mean ± SD. Student’s t-tests were employed for statistical analysis; *P < 0.05; **P < 0.01. Circ_0008777 can recruit PC4 to promote c-Myc transcription in HNSCC cells RNA pull-down assays were performed to identify the proteins that interact with circ_0008777. The proteins that were pulled down were sent for silver staining (Fig. 4A), with 10 proteins identified using mass spectrometry (Fig. 4B, Table S3). Next, we employed two indicators, the Support Vector Machine (SVM) classifier and Random Forest (RF) classifier, to forecast the binding potential between the target RNA and proteins of interest. The results indicated that circ_0008777 may interact with PC4 (RF: 0.7; SVM: 0.96), as well as with RL26L (RF: 0.7; SVM: 0.96), with a strong degree of credibility (Table S4). Western blot analysis of the proteins captured in the pull-down assay confirmed PC4 as a direct binding partner of circ_0008777 (Fig. 4B). Consistent with this, the RIP assay results revealed that circ_0008777 was significantly enriched in the precipitate collected using the anti-PC4 antibody, as confirmed by qPCR analysis (Fig. 4C, D). Further RNA pull-down assays showed that the 22–91 fragment of PC4, which was identified as a domain that is both necessary and sufficient for the PC4 coactivator function [16], was mainly responsible for its interaction with circ_0008777 (Fig. 4E, Figure S4G). PC4 can reportedly regulate c-Myc mRNA expression by binding to the c-Myc gene promoter, thereby supporting the malignant progression of prostate and breast cancers [17,18]. Our western blot analysis data indicated that circ_0008777 knockdown did not significantly impact the PC4 protein expression patterns, while it led to reduced c-Myc protein expression levels (Fig. 4F). Furthermore, qPCR analysis demonstrated that knocking down circ_0008777 resulted in decreased c-Myc mRNA expression levels (Fig. 4G). In addition, we constructed monoclonal Cal27 and Tu212 cell lines with stable PC4 knockout using the CRISPR-Cas9 system (Fig. 4H, Figure S4A-C). The western blot data indicated that PC4 knockout led to decreased c-Myc protein expression levels (Fig. 4H). ChIP-qPCR showed that knocking down circ_0008777 resulted in reduced binding of PC4 to the c-Myc gene promoter (Fig. 4I). To further confirm the specificity of PC4‑mediated regulation of c‑Myc, we examined the mRNA expression of several other genes in PC4‑knockout Tu212 cells by qPCR. As shown in Figure S4F, TAF1, POLR2A, and FOS mRNA levels remained unchanged upon PC4 knockout, while PCNA mRNA levels were reduced. These data indicate that PC4 knockout does not globally impair the transcriptional machinery, and the downregulation of c‑Myc is a specific regulatory event. In summary, these findings suggest that circ_0008777 can recruit PC4 to the c-Myc gene promoter to enhance its transcription in HNSCC cells. Circ_0008777 can bind to PC4 to enhance c-Myc transcription. A: Silver staining of circ_0008777 RNA pull-down assay products showing multiple differential bands in the probe group compared with the control group. B: Venn diagram showing the protein mass spectrometry analysis results of the circ_0008777 pull-down products. Compared with the control group, circ_0008777 can bind to 10 specific proteins. The circ_0008777-specific binding protein PC4 was validated by western blot analysis in Cal27 and Tu212 cells. C, D: RIP experiments confirmed that circ_0008777 can be pulled down using an anti-PC4 antibody. E: Schematic diagram showing the different constructed PC4 protein domains and the RNA pull-down results following transfection of these constructs into HEK293T cells. F: Knocking down circ_0008777 did not affect PC4 protein expression levels, but led to decreased c-Myc protein expression levels. G: Knocking down circ_0008777 also resulted in decreased c-Myc mRNA expression levels. H: Knocking out PC4 inhibited the expression of c-Myc. I: Knocking down circ_0008777 resulted in decreased binding of PC4 to the c-Myc gene promoter. Data are shown as the mean ± SD. Student’s t-tests were employed for statistical analysis; *P < 0.05; **P < 0.01. PC4 promotes HNSCC progression The results of the bioinformatics analysis indicated that PC4 is highly expressed in HNSCC patients (Figure S4D), with the survival analysis showing that PC4 expression is associated with the overall survival rate of HNSCC patients (Figure S4E). Furthermore, we conducted a series of cellular functional assays, including CCK-8, wound healing, colony formation, and Transwell assays, in HNSCC cells. The results demonstrated that knocking out PC4 significantly reduced the HNSCC cell proliferation and migration rates (Fig. 5A-H). Overall, this indicates that PC4 contributes to the progression of HNSCC. Knockout of PC4 inhibits HNSCC cell proliferation and migration A, B: CCK-8 assays showed that knocking out PC4 inhibited the proliferation of (A) Cal27 and (B) Tu212 cells. C, D: Knocking out PC4 inhibited clone formation in Cal27 and Tu212 cells. E, F: The effects of PC4 knockout on Cal27 and Tu212 cell migration were evaluated using Transwell migration assays. G, H: Knocking out PC4 inhibited the scratch healing ability of (E) Cal27 and (F) Tu212 cells. Data are shown as the mean ± SD. Student’s t-tests were employed for statistical analysis; *P < 0.05; **P < 0.01. Circ_0008777 acts as a sponge of miR-185–3p The sponge function of circRNA, which requires binding with AGO2 and miRNA to form a circRNA-AGO2-miRNA complex [19]. The AGO2-RIP results suggested that circ_0008777 can function as a miRNA sponge (Fig. 6A). Quantitative analysis further revealed that miR‑185‑3p was significantly enriched in the AGO2‑RIP precipitates compared with the IgG control (Figure S5A). To further screen for miRNAs that can bind to circ_0008777, we predicted potential miRNA binding sites using the circbank database [20]. Then, we intersected the predicted potential binding miRNAs with the downregulated miRNAs in HNSCC plasma samples [21] and the downregulated miRNAs in HNSCC tissue datasets (GEO data: GSE28100 and GSE124566), ultimately identifying miR-185–3p as a miRNA that can bind to circ_0008777 (Fig. 6B). Furthermore, we found that knocking down circ_0008777 in Cal27 and Tu212 cells led to increased miR-185–3p expression levels (Fig. 6C), while overexpressing circ_0008777 resulted in decreased miR-185–3p expression patterns (Fig. 6D). This indicated that circ_0008777 can regulate miR-185–3p expression. Finally, to further confirm that circ_0008777 can bind to miR-185–3p, we conducted a dual-luciferase reporter assay. Compared with the NC mimic group, miR-185–3p mimic treatment significantly reduced the luciferase activity of circ_0008777 WT. However, with circ_0008777 MT, no significant difference in luciferase activity was observed between the NC mimic and miR-185–3p mimic groups (Fig. 6E, F). Previous work has reported that miR-185–3p can inhibit the expression and activity of c-Myc in lung and colon cancer cells [22]. In addition, our western blot analysis showed that c-Myc protein expression levels were significantly decreased after miR-185–3p mimic transfection (Fig. 6G). Thus, these findings imply that circ_0008777 can function as a sponge for miR-185–3p, with c-Myc expression patterns affected by miR-185–3p. Circ_0008777 can regulate c-Myc expression by sponging miR-185–3p A: RIP experiment data showed that circ_0008777 can be pulled down using an anti-AGO2 antibody. B: Venn diagram showing the screening method for miR-185–3p bound to circ_0008777. C: qPCR analysis showing that knocking down circ_0008777 resulted in increased miR-185–3p expression levels. D: qPCR analysis showing that overexpression of circ_0008777 led to decreased miR-185–3p expression levels. E: The wild-type and mutated miR-185–3p binding site sequences within the circ_0008777 sequence. F: HEK-293T cells were co-transfected with miR-185–3p or control mimic with the wild-type or mutant circ_0008777 luciferase reporter vector, then luciferase reporter activity was detected. G: Cal27 and Tu212 cells were transfected with miR-185–3p or control mimic, then c-Myc protein expression levels were examined. Data are shown as the mean ± SD. Student’s t-tests were employed for statistical analysis; *P < 0.05; **P < 0.01. Circ_0008777 can accelerate HNSCC progression via c-Myc To further demonstrate that c-Myc is involved in the oncogenic mechanism of circ_0008777, we overexpressed c-Myc in circ_0008777-knockdown cells (Fig. 7A). The inhibitory effects of circ_0008777 knockdown on the cell migration (Fig. 7B–D) and proliferation (Fig. 7E) rates were rescued by c-Myc overexpression. The qPCR analysis revealed that CDK4 mRNA levels were significantly reduced by circ_0008777 knockdown and restored upon c‑Myc overexpression (Figure S5B/C). The qPCR results also indicated that the circ_0008777 expression levels were positively correlated with those of c-Myc mRNA (Fig. 7F). To exclude the possibility that circ_0008777 might affect its host gene AURKA at the protein level, we examined AURKA protein expression by Western blot in circ_0008777-knockdown Cal27 and Tu212 cells. No significant changes in AURKA protein levels were observed (Figure S5D), confirming that the functional effects of circ_0008777 are independent of AURKA protein. In addition, c-Myc remained significantly lower in circ_0008777‑knockdown Tu212 cells than in controls after MG132 treatment (Figure S5E), indicating that circ_0008777 knockdown reduces c-Myc expression primarily by decreasing its synthesis rather than enhancing its proteasomal degradation. Collectively, these results suggest that circ_0008777 exerts its oncogenic functions via activating c-Myc. C-Myc can reverse the inhibitory effects of circ_0008777 knockdown on HNSCC cell proliferation and migration. A: Western blot analysis was used to examine the c-Myc protein expression levels following overexpression in Cal27 and Tu212 cells with circ_0008777 knockdown. B, C: Scratch assays indicated that c-Myc overexpression mitigated the inhibitory effects of circ_0008777 knockdown on the migration of (B) Cal27 and (C) Tu212 cells. D: Transwell experiments showed that c-Myc overexpression reversed the inhibitory effects of circ_0008777 knockdown on HNSCC cell migration. E: CCK-8 assays were conducted to examine cell proliferation following c-Myc overexpression in Cal27 and Tu212 cells with circ_0008777 knockdown. F: Pearson correlation analysis showed that the expression levels of circ_0008777 were positively correlated with those of c-Myc mRNA. Data are shown as the mean ± SD. Student’s t-tests were employed for statistical analysis; *P < 0.05; **P < 0.01. Discussion Increasing evidence suggests that circRNAs play crucial roles in multiple tumor cell biological processes, such as metabolism, stemness, and immune evasion [[23], [24], [25]]. In this study, we identified a novel circRNA, circ_0008777, which is derived from exons 3, 4, 5, and 6 of the AURKA gene. Circ_0008777 expression levels were upregulated in HNSCC tissues compared with the adjacent normal tissues. Interestingly, upregulated circ_0008777 expression patterns correlated with HNSCC patient clinicopathological parameters, suggesting that circ_0008777 may serve as a candidate prognostic biomarker, although its clinical utility requires further evaluation. Functional assays indicated that knocking down circ_0008777 could significantly inhibit HNSCC cell proliferation and migration rates. Mechanistic studies also revealed that circ_0008777 can promote HNSCC progression by elevating c-Myc expression levels via interacting with PC4 and miR-185–3p (Fig. 8). While both pathways converge on c‑Myc upregulation, their relative contributions remain to be quantitatively determined. Based on our subcellular fractionation data, circ_0008777 is distributed in both compartments, but the absolute stoichiometry between circ_0008777 and its binding partners (PC4 and miR‑185‑3p) is unknown. Future studies using circ_0008777 mutants that selectively disrupt PC4 binding or miR‑185‑3p binding would help dissect the necessity and sufficiency of each pathway. Nevertheless, the complete rescue of the knockdown phenotype by c‑Myc overexpression indicates that c‑Myc is the central effector, and that both mechanisms ultimately contribute to c‑Myc elevation. Schematic illustration of HNSCC malignant progression regulation via the circ_0008777-PC4/miR-185–3p-c-Myc axis. CircRNAs can bind to proteins and impact their biological behaviors, including enhancing protein interactions, driving phase separation, and affecting protein localization [26,27]. Here, we found that circ_0008777 can bind to the co-activation domain of the PC4 protein in the nucleus, facilitating PC4 binding to the c-Myc gene promoter region, thereby enhancing its transcription. The PC4 gene (also known as coactivator p15 or PC4) is located on chromosome 5p13 and encodes a 127-amino acid protein that plays critical roles in various cellular processes, including transcription [28], DNA replication [29], and DNA repair [30]. Previous work has suggested that PC4 is highly expressed in lung cancer tissues, with PC4 knockdown affecting lung cancer cell cycle progression and apoptosis to significantly inhibit growth in vitro[31]. Additionally, PC4 is associated with colorectal cancer (CRC) metastasis. Mechanistically, PC4 activates the NF-κB signaling pathway and its transcriptional target genes, CXCL1 and CXCL3, to drive CRC metastasis [32]. However, the functional role of PC4 in HNSCC has not been reported. In the current study, we revealed that PC4 is significantly overexpressed in HNSCC, with its expression levels negative correlating with HNSCC patient overall survival. in vitrocellular experiments demonstrated that PC4 knockout markedly suppressed HNSCC cell proliferation and migration rates. In breast cancer patients, upregulated PC4 expression levels are positively correlated with metastasis and poor prognosis. PC4 can bind to the c-Myc promoter and mediate the Warburg effect to promote tumor cell proliferation and metastasis [18]. Studies have reported that the PC4 co-activation domain (22–91) is the minimal region required for its interaction with the Tat protein [33]. Furthermore, the PC4 co-activation domain (22–91) and Sp1 DNA-binding domain are essential for the PC4/Sp1 interaction, which enhances the binding to DNA and promotes target gene transcription [16]. Here, we revealed that circ_0008777 can bind to the PC4 co-activation domain to enhance c-Myc mRNA transcription. These findings expand the regulatory network of c-Myc by highlighting the role of circRNAs as transcriptional regulators. Although circRNAs can play multiple roles in cells, the most investigated function is serving as a miRNA sponge. Mechanistically, miRNA sponges can sequester specific miRNA molecules in the cytoplasm, which prevents them from inhibiting expression of their target genes [34]. Thus, circRNAs can indirectly affect the expression patterns of downstream target gene mRNAs. In this report, we demonstrated that cytoplasmic circ_0008777 can interact with miR-185–3p to regulate c-Myc mRNA expression levels. In HNSCC cells, miR-185–3p downregulates RAB25 expression levels, thereby inhibiting cell proliferation and migration [35]. Additionally, miR-185–3p acts as a mediator for circRNAs in regulating tumor progression. For example, circ_0058106 can promote hypopharyngeal squamous cell carcinoma progression by modulating the Wnt2b/β-catenin/c-Myc pathway through miR-185–3p [36]. Studies have also revealed that miR-185–3p is associated with chemoresistance in tumors, with Zhou et al. finding that miR-185–3p expression levels are downregulated in CRC tissues where it can enhance chemosensitivity by targeting AQP5 [37]. In our study, knocking down circ_0008777 in HNSCC cells altered the expression patterns of downstream target genes enriched in platinum-based drug resistance pathways, suggesting that circ_0008777 may mediate chemoresistance through miR-185–3p These findings further expand the regulatory network of circRNAs that target miR-185–3p, elucidating a novel mechanism by which circ_0008777 can drive HNSCC progression via the miR-185–3p/c-Myc axis. As a proto-oncogene, c-Myc is a highly expressed biomarker in various cancer types and serves as a critical regulator of tumor cell proliferation [38]. Studies have demonstrated that c-Myc can modulate multiple biological processes in the malignant progression of HNSCC, including cell proliferation, apoptosis, autophagy, and drug resistance [39]. Additionally, c-Myc activates NRF2 transcription to regulate G6PD- and TKT-mediated nucleotide biosynthesis, thereby promoting HNSCC progression [40]. Furthermore, c-Myc can regulate cisplatin sensitivity in HPV-positive HNSCC patients by mediating the transcription of autophagy-related genes [41]. Our study further expands the molecular mechanism by which circ_0008777 can drive HNSCC progression via c-Myc, suggesting that circ_0008777 is a potential therapeutic target for cancer treatment. Conclusion Our data suggest that circ_0008777 expression levels are upregulated in HNSCC tissues, with this high expression associated with poorer HNSCC patient clinicopathological characteristics. Mechanistically, circ_0008777 can support HNSCC progression by elevating c-Myc expression levels via interacting with PC4 and sponging miR-185–3p. Ethics approval and consent to participate This study was approved by the Research Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University. Animal procedures were authorized under the approval of the Institutional Animal Care and Use Committee of Jinan University. Availability of data and material The dataset(s) supporting the conclusions of this article is(are) included within the article (and its additional file(s)). Funding This work was supported by funds from the Science and Technology Program of Guangzhou (201903010024 and 202206010081), National Natural Science Foundation Cultivation Special Project Funding of The Third Affiliated Hospital of Sun Yat-sen University (2026GZRPYMS08), National Science Foundation of China (81902771, 81772540 and 82272996), and the Fundamental Research Funds for the Central Universities (21625105). CRediT authorship contribution statement Weixing Liu: Writing – review & editing, Writing – original draft, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Zhiyuan Wang: Writing – review & editing, Methodology, Investigation, Formal analysis, Data curation. Pei Li: Writing – review & editing, Methodology, Investigation, Funding acquisition, Formal analysis, Data curation. Yue Liu: Writing – review & editing, Formal analysis, Data curation. Jia Chen: Writing – review & editing, Formal analysis, Data curation. Zhi Shi: Writing – review & editing, Supervision, Funding acquisition, Formal analysis, Data curation, Conceptualization. Hui Liu: Writing – review & editing, Supervision, Formal analysis, Data curation, Conceptualization. Jin Ye: Writing – review & editing, Supervision, Funding acquisition, Conceptualization. Declaration of competing interest The authors declare that they have no conflict of interests. Acknowledgements We thank J. Iacona, Ph.D., from Liwen Bianji (Edanz) (www.liwenbianji.cn) for editing the English text of a draft of this manuscript. Footnotes Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.tranon.2026.102856. Contributor Information Zhi Shi, Email: tshizhi@jnu.edu.cn. Hui Liu, Email: liuhui27@mail.sysu.edu.cn. Jin Ye, Email: yejin@mail.sysu.edu.cn. Supplementary materials References Associated Data Supplementary Materials Data Availability Statement The dataset(s) supporting the conclusions of this article is(are) included within the article (and its additional file(s)).